PMC:7461420 / 84427-84691
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T302 | 46-50 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T396 | 41-44 | Disease | denotes | HAE | http://purl.obolibrary.org/obo/MONDO_0019623 |
T397 | 117-121 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T398 | 228-232 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T974 | 16-21 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T975 | 22-28 | http://purl.obolibrary.org/obo/UBERON_0001005 | denotes | airway |
T976 | 29-39 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T977 | 46-50 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T978 | 75-83 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T979 | 148-149 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T519 | 65-74 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T19063 | 98-108 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2598 | 16-21 | Species | denotes | human | Tax:9606 |
2599 | 117-125 | Species | denotes | SARS‐CoV | Tax:694009 |
2600 | 132-140 | Species | denotes | MERS‐CoV | Tax:1335626 |
2601 | 228-236 | Species | denotes | SARS‐CoV | Tax:694009 |
2602 | 254-262 | Species | denotes | MERS‐CoV | Tax:1335626 |
2607 | 98-108 | Chemical | denotes | remdesivir | MESH:C000606551 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T731 | 0-264 | Sentence | denotes | 220 In primary human airway epithelial (HAE) cell cultures, the antiviral activity assessment of remdesivir against SARS‐CoV‐1 and MERS‐CoV showed a dose‐dependent reduction in replication with average IC50 values of 0.069 µM (SARS‐CoV‐1) and 0.074 µM (MERS‐CoV). |